Belite Bio (BLTE) Return on Capital Employed (2023 - 2025)

Belite Bio's Return on Capital Employed history runs 3 years deep, the most recent figure standing at 2978301.27% for Q4 2025.

• On a quarterly basis, Return on Capital Employed fell 296360610.0% year-over-year to 2978301.27% in Q4 2025; TTM through Dec 2025 was 2978301.27%, a 296360610.0% decrease from a year earlier, with the FY2025 full-year figure at 18.45%, up 1564.0% from the prior year.
• Return on Capital Employed grew to 2978301.27% in Q4 2025 per BLTE's latest filing, from 7350732.03% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 14695.17% in Q4 2024 and bottomed at 7350732.03% in Q3 2025.
• The 3-year median for Return on Capital Employed is 1498648.83% (2023), against an average of 2590681.22%.
• Across the five-year window, Return on Capital Employed jumped 430122 bps in 2024 and plunged 296360610 bps in 2025, its largest moves.
• Year by year, Return on Capital Employed stood at 18996.39% in 2023, then rose by 23 bps to 14695.17% in 2024, then slumped by 20167 bps to 2978301.27% in 2025.
• Per Business Quant, the three latest BLTE Return on Capital Employed figures stand at 2978301.27% (Q4 2025), 7350732.03% (Q3 2025), and 14695.17% (Q4 2024).